Global /United States /Healthcare /Drug Manufacturers - General /INBP
chevron_leftBack
Integrated BioPharma, Inc. logo

Integrated BioPharma, Inc.

INBP
OTCMKTS: INBP Delayed
0.2650USD -1%
As of 13 June 2026, Integrated BioPharma, Inc. has a market cap of $8.23M USD, ranking #42281 globally and #5439 in the United States. It ranks #3742 in the Healthcare sector, and #1213 in the Drug Manufacturers - General industry.
Global Rank
42281
Country Rank
5439
Sector Rank
3742
Industry Rank
1213
Key Stats
Market Cap
$8.23MUSD
Enterprise Value
$3.42MUSD
Revenue (TTM)
$52.09MUSD
EBITDA (TTM)
$882.0KUSD
Net Income (TTM)
-$206.0KUSD
EBITDA Margin
1.7%
Profit Margin
-0.4%
PS Ratio
0.2
PB Ratio
0.4
EV/EBITDA
1.8
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
153
Founded
1980
Website
ir.ibiopharma.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-1% 0.4% -9.2% -22% -12% -11%

News

Loading...

Markets

Exchange Ticker Price
OTC Markets
MIC: OTCM
PRIMARY
INBP
Integrated Biopharma Inc
ISIN: US45811V1052
Shares Out.:
31.06M1 Shares Float: 9.34M2
TV:
SA:
YF:
GF:
BA:
MS:
0.2650 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Integrated BioPharma, Inc.

Integrated BioPharma, Inc., together with its subsidiaries, engages in the manufacturing, distributing, marketing and sale of vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. The company operates through two segments, Contract Manufacturing and Other Business Lines. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment provides warehousing and fulfilment services; and distributes raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.

Similar Companies

Industry: Drug Manufacturers - General (United States)
Name
Market Cap diff.
PE
LLY
$761.68B
9M%
38.1
JNJ
$547.28B
7M%
26.4
ABBV
$360.63B
4M%
97.4
MRK
$274.03B
3M%
15.1
PFE
$149.38B
2M%
19.5
$117.58B
1M%
16.8
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
$321.52B
256.25B CHF
4M%
19.9
AZN
$288.84B
215.59B GBP
4M%
27.6
NOVN
$274.65B
218.9B CHF
3M%
20.5
NOVO-B
$181.82B
1.18T DKK
2M%
11.5
SAN
$110.1B
95.26B EUR
1M%
19.9
GSK
$108.46B
80.96B GBP
1M%
14.6
chevron_leftBack